Effect of an Airbag-selective Portal Vein Blood Arrester on the Liver after Hepatectomy: A New Technique for Selective Clamping of the Portal Vein

Abstract

Objective

A novel technique was explored using an airbag-selective portal vein blood arrester that circumvents the need for an intraoperative assessment of anatomical variations in patients with complex intrahepatic space-occupying lesions.

Methods

Rabbits undergoing hepatectomy were randomly assigned to 4 groups: intermittent portal triad clamping (PTC), intermittent portal vein clamping (PVC), intermittent portal vein blocker with an airbag-selective portal vein blood arrester (APC), and without portal blood occlusion (control). Hepatic ischemia and reperfusion injury were assessed by measuring the 7-day survival rate, blood loss, liver function, hepatic pathology, hepatic inflammatory cytokine infiltration, hepatic malondialdehyde levels, and proliferating cell nuclear antigen levels.

Results

Liver damage was substantially reduced in the APC and PVC groups. The APC animals exhibited transaminase levels similar to or less oxidative stress damage and inflammatory hepatocellular injury compared to those exhibited by the PVC animals. Bleeding was significantly higher in the control group than in the other groups. The APC group had less bleeding than the PVC group because of the avoidance of portal vein skeletonization during hepatectomy. Thus, more operative time was saved in the APC group than in the PVC group. Moreover, the total 7-day survival rate in the APC group was higher than that in the PTC group.

Conclusion

Airbag-selective portal vein blood arresters may help protect against hepatic ischemia and reperfusion injury in rabbits undergoing partial hepatectomy. This technique may also help prevent liver damage in patients requiring hepatectomy.

Keywords

hepatectomy / portal vein / hepatic damage / selective clamping

References

[1]	Singh AK, Kumar R, Pandey AK. Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers. Curr Chem Genom Transl Med, 2018,12:9–26
[2]	Wei X, Zheng W, Yang Z, et al. Effect of the intermittent Pringle maneuver on liver damage after hepatectomy: a retrospective cohort study. World J Surg Oncol, 2019,17(1):142
[3]	Chen Y, Liu H, Zhang J, et al. Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China. BMC Cancer, 2021,21(1):1299
[4]	Irita K. Risk and crisis management in intraoperative hemorrhage: Human factors in hemorrhagic critical events. Korean J Anesthesiol, 2011,60(3):151–160
[5]	Otsubo T. Control of the inflow and outflow system during liver resection. J Hepatobiliary Pancreat Sci, 2012,19(1):15–18
[6]	Zhu P, Zhang B, Wang R, et al. Selective Inflow Occlusion Technique Versus Intermittent Pringle Maneuver in Hepatectomy for Large Hepatocellular Carcinoma: A Retrospective Study. Medicine (Baltimore), 2015,94(50):e2250
[7]	Chen YW, Li CH, Zhang AQ, et al. Preserving hepatic artery flow during portal triad blood inflow occlusion reduces liver ischemia-reperfusion injury in rats. J Surg Res, 2012,174(1):150–156
[8]	Eipel C, Abshagen K, Vollmar B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol, 2010,16(48):6046–6057
[9]	Liu J, Zhang Z, Song P, et al. Automatic Skeletonization for 3D Hepatic Portal Vein in CT Angiography. IEEE Nuclear Science Symposium Conference Record, 2008:5396–5399.
[10]	Li F, Ke H, Wang S, et al. Leaky Gut Plays a Critical Role in the Pathophysiology of Autism in Mice by Activating the Lipopolysaccharide-Mediated Toll-Like Receptor 4-Myeloid Differentiation Factor 88-Nuclear Factor Kappa B Signaling Pathway. Neurosci Bull, 2023,39(6):911–928
[11]	Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol, 2007,47(4):598–607
[12]	Rahal A, Kumar A, Singh V, et al. Oxidative stress, prooxidants, and antioxidants: the interplay. Biomed Res Int, 2014,2014:761264
[13]	Michalopoulos GK, Bhushan B. Liver regeneration: biological and pathological mechanisms and implications. Nat Rev Gastroenterol Hepatol, 2021,18(1):40–55
[14]	Konishi T, Schuster RM, Lentsch AB. Liver repair and regeneration after ischemia-reperfusion injury is associated with prolonged fibrosis. Am J Physiol Gastrointest Liver Physiol, 2019,316(3):G323–G331
[15]	Ji AL, Li T, Zu G, et al. Ubiquitin-specific protease 22 enhances intestinal cell proliferation and tissue regeneration after intestinal ischemia reperfusion injury. World J Gastroenterol, 2019,25(7):824–836
[16]	Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant, 2011,11(8):1563–1569
[17]	Wang AP, Migita K, Ito M, et al. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis. J Autoimmun, 2005,25(1):85–91
[18]	Kim WR, Flamm SL, Di Bisceglie AM, et al. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology, 2008,47(4):1363–1370
[19]	Kalas MA, Chavez L, Leon M, et al. Abnormal liver enzymes: A review for clinicians. World J Hepatol, 2021,13(11):1688–1698
[20]	Niedernhofer LJ, Daniels JS, Rouzer CA, et al. Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem, 2003,278(33):31426–31433
[21]	Li S, Tan HY, Wang N, et al. The Role of Oxidative Stress and Antioxidants in Liver Diseases. Int J Mol Sci, 2015,16(11):26087–26124
[22]	Kong Z, Hu JJ, Ge XL, et al. Preserving hepatic artery flow during portal triad blood occlusion improves regeneration of the remnant liver in rats with obstructive jaundice following partial hepatectomy. Exp Ther Med, 2018,16(3):1910–1918
[23]	Li CH, Chen YW, Chen YL, et al. Preserving low perfusion during surgical liver blood inflow control prevents hepatic microcirculatory dysfunction and irreversible hepatocyte injury in rats. Sci Rep, 2015,5:14406
[24]	Yamamoto T, Mori Y, Ishibashi T, et al. Interaction between proliferating cell nuclear antigen (PCNA) and a DnaJ induced by DNA damage. J Plant Res, 2005,118(2):91–97
[25]	Zhang S, Zhou T, Wang Z, et al. Post-Translational Modifications of PCNA in Control of DNA Synthesis and DNA Damage Tolerance-the Implications in Carcinogenesis. Int J Biol Sci, 2021,17(14):4047–4059
[26]	Zhao H, Ho PC, Lo YH, et al. Interaction of proliferation cell nuclear antigen (PCNA) with c-Abl in cell proliferation and response to DNA damages in breast cancer. PLoS One, 2012,7(1):e29416
[27]	Pu W, Zhou B. Hepatocyte generation in liver homeostasis, repair, and regeneration. Cell Regen, 2022,11(1):2
[28]	Wang PF, Li CH, Chen YW, et al. Preserving hepatic artery flow during portal triad blood inflow occlusion improves remnant liver regeneration in rats after partial hepatectomy. J Surg Res, 2013,181(2):329–336
[29]	Konishi T, Lentsch AB. Hepatic Ischemia/Reperfusion: Mechanisms of Tissue Injury, Repair, and Regeneration. Gene Expr, 2017,17(4):277–287
[30]	Duval H, Mbatchi SF, Grandadam S, et al. Reperfusion stress induced during intermittent selective clamping accelerates rat liver regeneration through JNK pathway. J Hepatol, 2010,52(4):560–569
[31]	Lu L, Zhou H, Ni M, et al. Innate Immune Regulations and Liver Ischemia-Reperfusion Injury. Transplantation, 2016,100(12):2601–2610
[32]	Wu HS, Zhang JX, Wang L, et al. Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int, 2004,3(2):250–253
[33]	Zhu P, Duan L, Chen J, et al. Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice. Hum Gene Ther, 2011,22(7):853–864
[34]	Xue R, Qiu J, Wei S, et al. Lycopene alleviates hepatic ischemia reperfusion injury via the Nrf2/HO-1 pathway mediated NLRP3 inflammasome inhibition in Kupffer cells. Ann Transl Med, 2021,9(8):631
[35]	Chen F, Zhang YM, Wang JT, et al. Pre-treatment with FK506 reduces hepatic ischemia-reperfusion injury in rats. Clin Res Hepatol Gastroenterol, 2019,43(2):161–170